Serum creatine kinase-BB levels and cerebral cortical creatine kinase activity in senile dementia of the Alzheimer type.
A rise in serum creatine kinase-BB (CK-BB) levels has been reported previously in cases of dementia. In the present study the levels of serum CK-BB have been measured in patients clinically assessed to have senile dementia of the Alzheimer's type (SDAT) and in cognitively intact individuals, matched for age, by a specific two-site monoclonal immunoradiometric assay. No significant difference was found between the 2 groups. Total creatine kinase activity in temporal cortex (Brodmann area 21 and 22) was also found to be similar in brains from SDAT or control cases, obtained at autopsy. These results suggest no major change in the permeability of the blood-brain barrier to this enzyme in SDAT patients.
D000544:Alzheimer Disease / Q000097:blood / Q000201:enzymology*; D003402:Creatine Kinase / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes; D013702:Temporal Lobe / Q000201:enzymology*
D007527:Isoenzymes; D003402:Creatine Kinase